Abstract: A granular bone substitute composed of alpha tricalcium phosphate, chondroitin sulfate and disodium succinate is biocompatible in vivo. The aim of this in vitro study was to analyze cellular aspects related to bone regeneration. The response of MG63 and L929 cells to liquid extracts of the respective material was reported. Viability and integrity of the cell membrane were determined by MTT and trypan blue exclusion assay. Cytoskeletal changes were followed by phalloidin staining. Expression of apoptotic, mitogenic and osteogenic differentiation genes was detected by RT-PCR. Supernatants obtained at 24 hours of extraction, but not later, reduced formazan formation in L929 and MG63 cells (p<0.05). Also sodium chondroitin sulfate at 10 % and disodium succinate at 2.5% significantly decreased cell viability (p<0.05). Moreover, we observed impaired integrity of the cell membrane and cytoskeletal changes. Expression of mitogenic genes was partially reduced while apoptotic and differentiation genes were unchanged. Liquid extracts of TCP and TCP failed to cause any substantial effects. Thus, the composite bone substitute can cause an early, but temporary cell necrosis. Since bone regeneration is initiated by a transient catabolic phase, the observed effects are in line with this biological principle.
Introduction
Bone regeneration is a sequential process initiated by a catabolic phase prior to the anabolic phase 1, 2) . The catabolic phase is characterized by an acid pH and the local release of proteases that help to prepare the defect site for the following anabolic phase that, in the optimal case, leads to a restitution ad integrum 3) . While bony defect below a critical size heal spontaneously, larger defects require a guidance for the newly formed bone to grow 4) . Thus, defects that exceed a critical size, but also those that have a complex morphology, the latter being frequently observed in the area of oral and maxillofacial surgery, require a transient bridging with bone grafts or the respective substitutes [5] [6] [7] [8] . The complex defect morphology is a challenge that can be overcome by design custom-made bone substitutes. The defect morphology is pictured by radiographic methods providing the structural information for the design of the bone substitutes. In the past decade, substantial effort has been made in advancing the CAD/CAM technology 9, 10) allowing for example, the printing of individualized bone substitutes [11] [12] [13] . Printing requires a combination of the bone substitutes such as tricalcium phosphate (TCP) and hydroxyapatite with a binder that serves as glue for the small-mineralized particles. Based on this technology, TCP and the malaxation liquid consisting of chondroitin sulfate and disodium succinate were tested in a clinical setting 11, 13) . The concept of combining mineralized components with chondroitin sulfate and disodium succinate is well established 14, 15) . Even though the preclinical and clinical data are promising, the underlying cellular mechanisms have not been evaluated in detail.
Calcium phosphates are largely used as bone substitutes. Although these materials have no osteogenic or osteoinductive properties 16) , they are biocompatible and possess one characteristic of an ideal graft: osteoconductivity. Particles released from TCP cements can provoke the formation of multinucleated giant cells 16) . Chondroitin sulfate and disodium succinate are water-soluble and therefore released upon contact with serum at the defect site. Chondroitin sulfate chains are unbranched polysaccharides containing two alternating monosaccharides. Chondroitin sulfate is a dietary supplement and a pharmacologic therapy in component, disodium succinate, is a salt used in the food industry, for example in cheeses production 20) . Thus, neither chondroitin sulfate nor disodium succinate is considered toxic, however, at higher unphysiologic concentrations, adverse reaction cannot be ruled out. Since chondroitin sulfate and disodium succinate are water-soluble, the moldable binder can provoke a transient cellular reaction upon placement into a defect site. To simulate and observe this early situation in vitro, we placed the composite biomaterial and its components in culture medium and tested the respective extracts in vitro. We assumed that supernatants immediately obtained from the bone substitutes support the inflammatory phase while supernatants obtained a later time points remain inert in this in vitro system.
Materials and Methods Materials
The TCP based bone substitute material (TBM) was kindly provided by Next21 KK (IPCAB: Injected-printed Custom-made artificial bones, Tokyo, Japan). TBM is constituted by TCP and a combination of disodium succinate and chondroitin sulfate as binding solution. As in another study previously reported 11) , one volume of TCP powder (Taihei Chemical Industrial, Osaka, Japan) was combined with 0.1 volumes of a binder containing 5 % chondroitin sulfate (Seikagaku, Tokyo, Japan) and 12 % disodium succinate (Wako, Osaka, Japan) in distilled water. The paste was subjected to an inkjet printer to obtain bone substitutes of the desired shape, which were immersed in the curing solution for 6 h and sterilized by autoclaving. The material was shipped to our laboratory where it was stored at room temperature.
Preparation of the supernatants and stock solutions
TBM was homogenized by a bone mill (R. Quétin Bone-Mill, Roswitha Quétin Dental-Products, Leimen, Germany Instruments, Winooski, VT). In addition, MG63 cells were treated with corresponding liquid extracts from TCP and TCP.
Actin staining and dye exclusion assay
Cells were stimulated with TBM extracts, chondroitin sulfate, and disodium succinate for one hour. For actin staining, the cells were fixed with 4 % paraformaldehyde and permeabilized with cold acetone. Cells were then incubated with the phalloidine stain (Texas Red ® -X phalloidine, Life Technologies) and DAPI (4',6-Diamidino-2-phenylindole, Sigma-Aldrich) before being analyzed by fluorescence microscopy (X-Cite 120Q, Mississauga, Canada and BX51TF, Olympus, Tokyo, Japan) and photographed (ProgRes, Jenoptik, Jena, Germany). For the dye exclusion assay, cells were exposed to 0.1 % trypan blue (Inselspital, Bern, Switzerland) and light microscopy pictures were taken immediately thereafter (Leica DMIL LED and Leica DFC 420, Leica
Microsystems, Wetzlar, Germany).
Alkaline phosphatase staining for differentiation MG63 cells were stimulated with TBM, TCP and TCP extracts at a dilution of 50 % in the presence of 5 %FCS for 3 days. Cells were fixated with 10 % neutral buffered formalin and incubated with a substrate solution containing Fast Blue BB and Naphthol AS-TR phosphate disodium salt (Sigma-Aldrich) for 30 min at 37 °C. Cells were washed with PBS and photographed.
RNA extraction and reverse transcriptase-polymerase chain reaction
L929 and MG63 were stimulated with TBM extracts,chondroitin sulfate, and disodium succinate for one hour and three days, respectively. Total RNA was prepared (High Pure RNA Isolation Kit, Roche, Basel, Switzerland), transcribed into cDNA (Transcriptor Universal cDNA Master; Roche), and subjected to amplification with a SYBR Green detection system (FastStart Universal SYBR Green Master; Roche). Amplification was performed in the 7500 Real Time PCR System (Applied Biosystems, Foster City, CA). Mouse primer sequences were as follows: mb-actin forw. 
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Statistical analysis and study plan
Statistical analysis of MTT data was performed with ANOVA and post-hoc testing with alpha 5 %. All other analysis were based on a t-test.
Results
Cell viability: MTT assay
When TBM was placed into culture medium, the components of the moldable binder were eluted and accumulated in the supernatant. This process was repeated, so the amount of eluted have used these supernatants in the viability test. In line with this assumption, the supernatants of the first elution substantially formation (Table 1) . Importantly, the supernatants harvested at later time points have no detrimental effects on the two cell lines.
To determine the role of the binder, the experiments were performed with solutions of chondroitin sulfate and disodium succinate. In agreement with the data from the TBM extracts, sodium chondroitin sulfate at 10 % and disodium succinate at 2.5 % significantly decreased cell viability (p<0.05; Figure 1 , Tables  1, 2 ). Liquid extracts of TCP or TCP caused no significant changes in cell viability (Table 3 ).
Cell viability: trypan blue assay
To better understand the reason why the cell viability is deceased, cells were exposed to TBM extracts, and to 2.5 % dilutions of chondroitin sulfate and disodium succinate for one hour. This setting provided insights into an immediate early response of the cells. Cell morphology changed considerably as indicated by the higher number of cells that rounds up. In line with these findings, trypan blue staining demonstrated that the supernatants, but also the single components of the binder, disrupted the cell membrane. The disrupted membranes indicate cell necrosis, which was most pronounced in the presence of disodium succinate (Figs 2, 3) . Overall, the data show that the supernatant and particularly disodium succinate forced membrane disruption.
Cell morphology by phalloidin
To further confirm the rapid morphological changes of cells in response to TBM extracts, phalloidine stain of actin was performed. In the presence of TBM extracts, but also of 2.5 % of chondroitin sulfate and disodium succinate, the actin filaments were shrunken and the normal cell anatomy was lost. Cell detachment was denoted after sequential washing. Again, particularly disodium succinate promoted detachment and actin filaments contraction (Figs 4, 5) . Together, the data show that high concentrations of TBM extracts and the binders induce morphological changes, indicating the occurrence of cell necrosis.
Real time polymerase chain reaction
We next ruled out that the rapid changes induced by TBM extracts and the binders were associated with the occurrence of apoptosis. Four apoptotic genes belonging to the family B-cell lymphoma 2 (the Bcl-2) were included in the analysis e.g. nonapoptotic (Bcl-2, Bcl-x) and apoptotic (Bax, Bad) genes. None of the genes was considerably changed, indicating the absence of cell apoptosis and discarding the possibility of programmed cell death within this short time period (Table 4) .
Testing of TBM extracts versus aTCP or bTCP
To better understand the role of TCP alone and also TCP, experiments on proliferation and osteogenic differentiation were performed. TBM decreased the expression levels of MYBL2 and CCNB1 by 51 % ± 0.11 and 50 % ± 0.04, respectively. Again, liquid extracts of TCP and TCP failed to change the expression of MYBL2 and CCNB1 compared to controls (Table 5) . Under the same conditions, however, the expression of both osteogenicdifferentiation markers, alkaline phosphatase and osteocalcin, at the RNA level (Table 5) or by histochemical staining of alkaline phosphatase was not considerably altered by any of the three liquid extracts (Fig. 6 ).
Discussion
Our main findings indicate that medium extracts of TBM can reduce in vitro cell viability. This effect is restricted to 24 h TBM extracts, as well to chondroitin sulfate and disodium succinate at concentrations equal or higher than 2.5 %. Decreased cell viability is associated with the rapid loss of membrane integrity demonstrated by the permeability of cells for trypan blue and morphological changes of the cytoskeleton. Cell death by apoptosis can be ruled out as the respective genes remained unchanged. Our vitro data should be interpreted with the understanding that clinical testing of TBM was successful 11, 13) .
Even though liquid extraction is a standard procedure in biomaterial testing according to the ISO 10993, our study was the first to handle medium extracts of TBM. Usually, cells are seeded onto TCP discs for evaluation of viability and attachment.
With this approach, TCP based materials can either decrease 21) or increase cellular parameters in vitro 22, 23) . TCP extracts caused moderately stimulated cell viability, proliferation and osteogenic differentiation 24, 25) . TCP and TCP are considered safe and osteoconductive bone substitute materials 26) . However, cements containing TCP can release unset particles which in turn provoke a foreign body giant cell reaction 16) . The toxic reactions seen in this study are probably directly related to the biding solution of the CAD/CAM tested material. Nevertheless, chondroitin sulfate is used as a scaffold for chondrocytes and the respective progenitors 27, 28) . Surprisingly, however, no in vitro data on the impact of disodium succinate on any kind of cells are available to us. Thus, when we compared our findings with those of others, we experienced a lack of data available.
The question arises as to what is the underlying reason for the rapid loss of cell integrity. As death by apoptosis was excluded through gene expression, the disrupted actin filaments observed by phalloidin assay may be compatible to an osmotic reaction 29) , leading to cell necrosis. Cells, which lose water in a high concentrated environment normally, lose their natural morphology, having their anatomy more contracted than the living cells, and die 30) . Yet importantly, reaching osmotic pressure might also cause the strong peak between toxic and non-toxic disodium succinate concentrations in the present study. Among the limitations of this study is that specific osmolality stress tests were not included in our series of experiments. Further studies should consider changes of osmolality on the same cells.
In vivo, TCP is an established bone substitute 31-33) and chondroitin sulfate is used in osteoarthritis therapy 34) .
According to the Food and Drug Administration, the nonneutralized form from disodium succinate, the succinic acid, is safe, even though biocompatibility studies in vivo are missing. Finally, TBM works in vivo 11, 13) . The question
is now: what is the clinical relevance of our in vitro work showing the devastating effects of fresh extracts of TBM?
It can be assumed from our data that this material can cause an early and temporary limited inhibition of bone formation in vitro. Based on the existing in vivo evidence, however, the observed early cellular toxicity might coincide with bone regeneration process in the long run, after TBM is placed into defect sites. 
